Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $plrx

Pliant Therapeutics ($PLRX) is seeing significant social media buzz around potential merger or acquisition speculation, fueled by investor filings and its stock trading below cash value. Despite some critical themes of downgrades and a shrinking community, the market is reacting to potential undervaluation and strategic alternatives.

### About $plrx
Pliant Therapeutics is a biotechnology company.  

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$plrx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$plrx/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXX  
X Week: XXXXX -XX%  
X Month: XXXXXX -XX%  
X Months: XXXXXXX -XX%  
X Year: XXXXXXXXX +197%  
1-Year High: XXXXXXX on 2025-02-11  
1-Year Low: X on 2025-09-29  

Engagements by network (24h):
Reddit: XX
X: XXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$plrx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$plrx/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX +155%  
X Months: XXXXX +432%  
X Year: XXXXX +1,244%  
1-Year High: XXX on 2025-06-30  
1-Year Low: X on 2025-09-28  

Mentions by network (24h):
Reddit: XX
X: XX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$plrx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$plrx/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $plrx in the last XX hours which is no change from in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XX +95%  
X Months: XXXXX +803%  
X Year: XXXXX +1,531%  
1-Year High: XXX on 2025-06-30  
1-Year Low: X on 2025-05-13  

The most influential creators that mention $plrx in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | X    | XX        | X     | XXX         |
| [@DrBunnybio](/creator/twitter/DrBunnybio)           | X    | XX        | X     | XX          |
| [@Fredbenz0](/creator/twitter/Fredbenz0)             | X    | XXXXX     | X     | XX          |
| [@TheOptionsBull2](/creator/twitter/TheOptionsBull2) | X    | XXX       | X     | X           |

[View More](/list/creators/$plrx/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$plrx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$plrx/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -XX%  
X Month: XX% -XX%  
X Months: XX% +17%  
X Year: XX% +47%  
1-Year High: XXX% on 2025-01-12  
1-Year Low: XX% on 2024-12-15  

Most Supportive Themes:
- Potential Merger/Acquisition Speculation: (40%) Filings from Point72 and Tang Capital are fueling speculation of a potential merger or liquidation for $PLRX, with some seeing it as a bargain below cash value.
- Undervalued Asset Below Cash Value: (30%) The asset is currently trading significantly below its cash value, attracting attention from investors and making it appear as a bargain.
  
Most Critical Themes:
- Downgrades and Shrinking Community: (30%) The asset is facing downgrades and a shrinking community, which could negatively impact its future prospects.
  

### Top $plrx Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$CMTL $GANX $INV $NUAI $ORBS $ABR $ABVX $BTM $CCL $CCOI $CELH $CODI $DBRG $DDOG $FIP $GEV $LAKE $MREO $MTN $PINS $SBGI $TERN $VALE $WRBY $ANF $AVGO $AHT $CBIO $CCRN $DOMO $KALV $PLRX πŸ’Ž 12/10/25-Part X πŸ’ŽTop Unusual Implied Volatility Watchlist & Database πŸ’ŽIV Change Details For 100+ Stocks (Secondary Unusual Options Alert)"  
[X Link](https://x.com/Fredbenz0/status/1999103380015202738) [@Fredbenz0](/creator/x/Fredbenz0) 2025-12-11T13:06Z 2691 followers, XXX engagements


"Stifel just dropped a 324-page biotech outlook for 2026. Can send the PDF if theres interest. $ACRS $ANAB $APGE $ARGX $ASND $AVTX $CGEM $CLDX $CRNX $DNTH $IMVT $JBIO $KYMR $MLTX $ORKA $PLRX $SYRE $TVTX $VRDN $VTYX"  
[X Link](https://x.com/BottomUpEquity/status/1998917628224786792) [@BottomUpEquity](/creator/x/BottomUpEquity) 2025-12-11T00:47Z 1253 followers, 1209 engagements


"Was there an official statement by the company that they really search for strategic alterantives They announced a restructuring and cut XX% of employees but the company itself still has XX employees. There was a 13D by Tang that he discusses changes with the company but as far as I know no real committment from $PLRX to some kind of strategic alternatives. Company itself said at Piper some days ago they want to go ahead with a new study in H1 2026"  
[X Link](https://x.com/Lord_of_Biotech/status/1998725881825562916) [@Lord_of_Biotech](/creator/x/Lord_of_Biotech) 2025-12-10T12:05Z 3440 followers, XXX engagements


"$PLRX is a biopharma net-net at XX% below year-end cash. - Tang Capital owns XX% (underwater here) - Only P1 asset remains (still moving forward) - Though mgmt just cut the Chief Biz and Chief Science officers - Strategic alts ongoing Feels primed for a Tang-style buyout"  
[X Link](https://x.com/InvestSpecial/status/1998724686209851685) [@InvestSpecial](/creator/x/InvestSpecial) 2025-12-10T12:01Z 32.6K followers, 4963 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$plrx

Pliant Therapeutics ($PLRX) is seeing significant social media buzz around potential merger or acquisition speculation, fueled by investor filings and its stock trading below cash value. Despite some critical themes of downgrades and a shrinking community, the market is reacting to potential undervaluation and strategic alternatives.

About $plrx

Pliant Therapeutics is a biotechnology company.

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX +197%
1-Year High: XXXXXXX on 2025-02-11
1-Year Low: X on 2025-09-29

Engagements by network (24h): Reddit: XX X: XXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXX +155%
X Months: XXXXX +432%
X Year: XXXXX +1,244%
1-Year High: XXX on 2025-06-30
1-Year Low: X on 2025-09-28

Mentions by network (24h): Reddit: XX X: XX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $plrx in the last XX hours which is no change from in the previous XX hours Daily Average: XX
X Week: XX -XX%
X Month: XX +95%
X Months: XXXXX +803%
X Year: XXXXX +1,531%
1-Year High: XXX on 2025-06-30
1-Year Low: X on 2025-05-13

The most influential creators that mention $plrx in the last XX hours

Creator Rank Followers Posts Engagements
@BuyTheUgly X XX X XXX
@DrBunnybio X XX X XX
@Fredbenz0 X XXXXX X XX
@TheOptionsBull2 X XXX X X

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% +17%
X Year: XX% +47%
1-Year High: XXX% on 2025-01-12
1-Year Low: XX% on 2024-12-15

Most Supportive Themes:

  • Potential Merger/Acquisition Speculation: (40%) Filings from Point72 and Tang Capital are fueling speculation of a potential merger or liquidation for $PLRX, with some seeing it as a bargain below cash value.
  • Undervalued Asset Below Cash Value: (30%) The asset is currently trading significantly below its cash value, attracting attention from investors and making it appear as a bargain.

Most Critical Themes:

  • Downgrades and Shrinking Community: (30%) The asset is facing downgrades and a shrinking community, which could negatively impact its future prospects.

Top $plrx Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$CMTL $GANX $INV $NUAI $ORBS $ABR $ABVX $BTM $CCL $CCOI $CELH $CODI $DBRG $DDOG $FIP $GEV $LAKE $MREO $MTN $PINS $SBGI $TERN $VALE $WRBY $ANF $AVGO $AHT $CBIO $CCRN $DOMO $KALV $PLRX πŸ’Ž 12/10/25-Part X πŸ’ŽTop Unusual Implied Volatility Watchlist & Database πŸ’ŽIV Change Details For 100+ Stocks (Secondary Unusual Options Alert)"
X Link @Fredbenz0 2025-12-11T13:06Z 2691 followers, XXX engagements

"Stifel just dropped a 324-page biotech outlook for 2026. Can send the PDF if theres interest. $ACRS $ANAB $APGE $ARGX $ASND $AVTX $CGEM $CLDX $CRNX $DNTH $IMVT $JBIO $KYMR $MLTX $ORKA $PLRX $SYRE $TVTX $VRDN $VTYX"
X Link @BottomUpEquity 2025-12-11T00:47Z 1253 followers, 1209 engagements

"Was there an official statement by the company that they really search for strategic alterantives They announced a restructuring and cut XX% of employees but the company itself still has XX employees. There was a 13D by Tang that he discusses changes with the company but as far as I know no real committment from $PLRX to some kind of strategic alternatives. Company itself said at Piper some days ago they want to go ahead with a new study in H1 2026"
X Link @Lord_of_Biotech 2025-12-10T12:05Z 3440 followers, XXX engagements

"$PLRX is a biopharma net-net at XX% below year-end cash. - Tang Capital owns XX% (underwater here) - Only P1 asset remains (still moving forward) - Though mgmt just cut the Chief Biz and Chief Science officers - Strategic alts ongoing Feels primed for a Tang-style buyout"
X Link @InvestSpecial 2025-12-10T12:01Z 32.6K followers, 4963 engagements

$plrx
/topic/$plrx